A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.
The best Bull and Bear pitches based on recency and number of recommendations.
Just as Obama enthusiasm for stem cell stocks is senseless, Obama pessimism for pharmaceuticals is overblown. I don't believe his policies will fundamentally change the business model or profitability of mid-to-large cap biotechs, and I see this as… More
Read the most recent pitches from players about GENZ.DL.
Find the members with the highest scoring picks in GENZ.DL.
See what the Wall Street professionals think, according to their public statements and filings.